Alternative splicing of the pituitary adenylate cyclase-activating polypetide (PACAP) receptor contributes to function of PACAP-27

Journal of Molecular Neuroscience

Volumn 42, Issue 3, 2010, Pages 341-348

  Ushiyama, Mina ^a,b   Ikeda, Ryuji ^b   Yoshida, Morikatsu ^c   Mori, Kenji ^c   Kangawa, Kenji ^c   Sugawara, Hideki ^b   Inoue, Kazuhiko ^a   Yamada, Katsushi ^b   Miyata, Atsuro ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY HOSPITAL   (Japan)

^c NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Binding affinity; cAMP; Intracellular calcium concentration; PAC1; PACAP 27; PACAP specific receptor

Indexed keywords

CYCLIC AMP; DUAL SPECIFICITY PHOSPHATASE 2; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE 27; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR; ISOPROTEIN;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CALCIUM MOBILIZATION; CHO CELL; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; INTRACELLULAR MEMBRANE; MALE; MOUSE; NONHUMAN; PHYSIOLOGICAL PROCESS; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ALTERNATIVE SPLICING; ANIMALS; CALCIUM; CHO CELLS; CRICETINAE; CRICETULUS; CYCLIC AMP; MICE; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; PROTEIN ISOFORMS; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE, TYPE I;

EID: 78349309253     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12031-010-9385-2     Document Type: Article

References (32)

1. H Aino H Hashimoto N Ogawa, et al. 1995 Structure of the gene encoding the mouse pituitary adenylate cyclase-activating polypeptide receptor Gene 164 301 304 1:CAS:528:DyaK2MXpsV2jsro%3D 10.1016/0378-1119(95)00391-I 7590347
2. D Alexandre H Vaudry L Grumolato, et al. 2002 Novel splice variants of type I pituitary adenylate cyclase-activating polypeptide receptor in frog exhibit altered adenylate cyclase stimulation and differential relative abundance Endocrinology 143 2680 2692 1:CAS:528:DC%2BD38XltVymtrs%3D 10.1210/en.143.7.2680 12072402
3. A Arimura A Somogyvári-Vigh A Miyata K Mizuno DH Coy C Kitada 1991 Tissue distribution of PACAP as determined by RIA: highly abundant in the rat brain and testes Endocrinology 129 2787 2789 1:CAS:528:DyaK3MXmsVyntbY%3D 10.1210/endo-129-5-2787 1935809
4. Ascuitto RJ, Ross-Ascuitto NT, Waddell AE, Kadowitz PJ (1996) Contractile and coronary vascular effects of pituitary adenylate cyclase activating polypeptide in neonatal pig hearts. Cardiovasc Res E153-159
5. S Bourgault D Vaudry I Ségalas-Milazzo, et al. 2009 Molecular and conformational determinants of pituitary adenylate cyclase-activating polypeptide (PACAP) for activation of the PAC1 receptor J Med Chem 52 3308 3316 1:CAS:528:DC%2BD1MXltlKlsro%3D 10.1021/jm900291j 19413310
6. TK Chatterjee RV Sharma RA Fisher 1996 Molecular cloning of a novel variant of the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor that stimulates calcium influx by activation of L-type calcium channels J Biol Chem 271 32226 32232 1:CAS:528:DyaK2sXit1anuw%3D%3D 10.1074/jbc.271.50. 32226 8943280
7. FM Dautzenberg G Mevenkamp S Wille RL Hauger 1999 N-terminal splice variants of the type I PACAP receptor: isolation, characterization and ligand binding/selectivity determinants J Neuroendocrinol 11 941 949 1:CAS:528:DyaK1MXotVKiurY%3D 10.1046/j.1365-2826.1999.00411.x 10583729
8. PE Gottschall I Tatsuno A Miyata A Arimura 1990 Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide Endocrinology 127 272 277 1:CAS:528: DyaK3cXlt1KktrY%3D 10.1210/endo-127-1-272 2361473
9. P Gourlet A Vandermeers MC Vandermeers-Piret P De Neef P Robberecht 1996 Addition of the (28-38) peptide sequence of PACAP to the VIP sequence modifies peptide selectivity and efficacy Int J Pept Protein Res 48 391 396 1:CAS:528:DyaK28Xmslyit70%3D 10.1111/j.1399-3011.1996.tb00856.x 8919060
10. M Hirose Y Furukawa Y Nagashima M Lakhe S Chiba 1997 Pituitary adenylate cyclase-activating polypeptide-27 causes a biphasic chronotropic effect and atrial fibrillation in autonomically decentralized, anesthetized dogs J Pharmacol Exp Ther 283 478 487 1:CAS:528:DyaK2sXnsV2nu7w%3D 9353360
11. M Hirose Y Furukawa Y Nagashima M Lakhe Y Miyashita S Chiba 1997 PACAP-27 causes negative and positive dromotropic effects in anesthetized dogs Eur J Pharmacol 338 35 42 1:CAS:528:DyaK2sXmvFWjs74%3D 10.1016/S0014-2999(97)01312-5 9408001
12. M Hirose Y Furukawa Y Nagashima K Yamazaki Y Hoyano S Chiba 1997 Effects of PACAP-38 on the SA nodal pacemaker activity in autonomically decentralized hearts of anesthetized dogs J Cardiovasc Pharmacol 29 216 221 1:CAS:528:DyaK2sXhsFGmsbw%3D 10.1097/00005344-199702000-00010 9057071
13. DB Hoover JD Tompkins RL Parsons 2009 Differential activation of guinea pig intrinsic cardiac neurons by the PAC1 agonists maxadilan and pituitary adenylate cyclase-activating polypeptide 27 (PACAP27) J Pharmacol Exp Ther 331 197 203 1:CAS:528:DC%2BD1MXht1GjtL7F 10.1124/jpet.109.155747 19602551
14. T Ishihara R Shigemoto K Mori K Takahashi S Nagata 1992 Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide Neuron 8 811 819 1:CAS:528:DyaK3sXit1Kis7o%3D 10.1016/0896-6273(92) 90101-I 1314625
15. M Laburthe A Couvineau V Tan 2007 Class II G protein-coupled receptors for VIP and PACAP: structure, models of activation and pharmacology Peptides 28 1631 1639 1:CAS:528:DC%2BD2sXhtVWms7jF 10.1016/j.peptides.2007.04.026 17574305
16. EM Lutz WJ Sheward KM West JA Morrow G Fink AJ Harmar 1993 The VIP2 receptor: molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide FEBS Lett 334 3 8 1:CAS:528:DyaK2cXps1aksg%3D%3D 10.1016/0014-5793(93)81668-P 8224221
17. EM Lutz S Shen M Mackay K West AJ Harmar 1999 Structure of the human VIPR2 gene for vasoactive intestinal peptide receptor type FEBS Lett 458 197 203 1:CAS:528:DyaK1MXlvVCgtL4%3D 10.1016/S0014-5793(99)01135-7 10481065
18. 2+ flux assays for high-throughput screening J Biomol Screen 10 780 787 1:CAS:528:DC%2BD28XktVCrsQ%3D%3D 10.1177/1087057105279493 16234348
19. A Miyata A Arimura RR Dahl, et al. 1989 Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells Biochem Biophys Res Commun 164 567 574 1:CAS:528:DyaK3cXps1Y%3D 10.1016/0006-291X(89)91757-9 2803320
20. A Miyata L Jiang RD Dahl, et al. 1990 Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38) Biochem Biophys Res Commun 170 643 648 1:CAS:528:DyaK3MXhslKgtA%3D%3D 10.1016/0006-291X(90)92140-U 2383262
21. K Mori M Miyazato T Ida, et al. 2005 Identification of neuromedin S and its possible role in the mammalian circadian oscillator system EMBO J 24 325 335 1:CAS:528:DC%2BD2MXmslOmsQ%3D%3D 10.1038/sj.emboj.7600526 15635449
22. Mustafa T, Grimaldi M, Eiden LE. The hop cassette of the PAC1 receptor confers coupling to Ca2+ elevation required for pituitary adenylate cyclase-activating polypeptide-evoked neurosecretion. J Biol Chem 282:8079-8091
23. C Pantaloni P Brabet B Bilanges, et al. 1996 Alternative splicing in the N-terminal extracellular domain of the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor modulates receptor selectivity and relative potencies of PACAP-27 and PACAP-38 in phospholipase C activation J Biol Chem 271 22146 22151 1:CAS:528:DyaK28XlsFKntLs%3D 10.1074/jbc.271.36.22146 8703026
24. JR Pisegna SA Wank 1996 Cloning and characterization of the signal transduction of four splice variants of the human pituitary adenylate cyclase activating polypeptide receptor. Evidence for dual coupling to adenylate cyclase and phospholipase C J Biol Chem 271 17267 17274 1:CAS:528:DyaK28XksFamt7s%3D
25. D Spengler C Waeber C Pantaloni, et al. 1993 Differential signal transduction by five splice variants of the PACAP receptor Nature 365 170 175 1:CAS:528:DyaK2cXntVY%3D 10.1038/365170a0 8396727
26. I Tatsuno PE Gottschall K Koves A Arimura 1990 Demonstration of specific binding sites for pituitary adenylate cyclase activating polypeptide (PACAP) in rat astrocytes Biochem Biophys Res Commun 168 1027 1033 1:CAS:528: DyaK3cXktlCqtrk%3D 10.1016/0006-291X(90)91132-C 2346475
27. M Ushiyama H Sugawara K Inoue K Kangawa K Yamada A Miyata 2006 Characterization of the PAC1 variants expressed in the mouse heart Ann N Y Acad Sci 1070 586 590 1:CAS:528:DC%2BD28XpvVegs78%3D 10.1196/annals.1317.086 16888230
28. M Ushiyama R Ikeda H Sugawara, et al. 2007 Differential intracellular signaling through PAC1 isoforms as a result of alternative splicing in the first extracellular domain and the third intracellular loop Mol Pharmacol 72 103 111 1:CAS:528:DC%2BD2sXnsVyjsLs%3D 10.1124/mol.107.035477 17442841
29. A Vandermeers S Vandenorre X Hou, et al. 1992 Antagonistic properties are shifted back to agonistic properties by further N-terminal shortening of pituitary adenylate-cyclase-activating peptides in human neuroblastoma NB-OK-1 cell membranes Eur J Biochem 20 815 819 10.1111/j.1432-1033.1992.tb17252.x
30. T Yada M Sakurada K Ihida, et al. 1994 Pituitary adenylate cyclase activating polypeptide is an extraordinarily potent intra-pancreatic regulator of insulin secretion from islet beta-cells J Biol Chem 269 1290 1293 1:CAS:528:DyaK2cXmvFynsw%3D%3D 8288592
31. 2+ responses to sub-picomolar and nanomolar PACAP in pancreatic beta-cells are mediated by VPAC2 and PAC1 receptors Regul Pept 123 147 153 1:CAS:528:DC%2BD2cXptFOltLY%3D 10.1016/j.regpep.2004.03.020 15518905
32. T Yonezawa Y Furukawa M Lakhe Y Nagashima M Hirose S Chiba 1996 PACAP-38 activates parasympathetic nerves in isolated, blood-perfused dog atria Eur J Pharmacol 315 289 296 1:CAS:528:DyaK28XntFajsL4%3D 10.1016/S0014-2999(96)00609-7 8982667